Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma

Phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway is extensively explored in cancers. It functions as an important regulator of cell growth, survival and metabolism. Activation of this pathway also predicts poor prognosis in numerous human malignancies....

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Xiaosheng, Zhou, Xiangxiang, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177547/
https://www.ncbi.nlm.nih.gov/pubmed/24252186
http://dx.doi.org/10.1186/2050-7771-1-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177547/
https://www.ncbi.nlm.nih.gov/pubmed/24252186
http://dx.doi.org/10.1186/2050-7771-1-30

Ejemplares similares